Course Exam
301907 VO Development of novel cancer immunotherapies (2024W)
from target identification through target validation to clinical trials
Labels
WHEN?
Monday
03.03.2025
15:00 - 17:00
BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Tu 01.10.2024 09:00 to Su 02.03.2025 09:00
- Deregistration possible until Su 02.03.2025 09:00
Examiners
Information
Examination topics
The lecture concludes with a written exam
the exam consists of 5 multiple choice and 5 open questions
the exam consists of 5 multiple choice and 5 open questions
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: Th 19.12.2024 12:06